Skip to content
Screener

Amylyx Pharmaceuticals, Inc. AMLX Total costs & expenses

Total costs & expenses at other companies

Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$151.11M+35.2%
uniQure logo
uniQureQURE
$51.68M+4.3%
AdaptHealth logo
AdaptHealthAHCO
$814.31M+7.9%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$45.7M-6.6%
Net income-$43.4M-4.8%
EPS (diluted)-$0.39+15.2%

Balance sheet

See full
Cash & equivalents$49.3M-15.1%
Total debt$5.3M-11.9%
Total equity$239.2M+42.5%
Total assets$264.6M+36.0%

Cash flow

See full
Operating cash flow-$31.4M-24.5%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$2.53B+262%
Enterprise value$2.48B+285%

Profitability

See full
Gross margin100%+6.9pp
Operating margin-47,349.8%-47,409pp
Net margin-45,096.2%-45,152pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-74.7%-9.5pp
Debt / equity0.0×
Current ratio12.1×+3.4×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:04 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336682

FAQ

What is Amylyx Pharmaceuticals, Inc.'s total costs & expenses?
Amylyx Pharmaceuticals, Inc. (AMLX) reported total costs & expenses of $45.69M in Q2 2026.
How has Amylyx Pharmaceuticals, Inc.'s total costs & expenses changed year-over-year?
Amylyx Pharmaceuticals, Inc.'s total costs & expenses increased by 6.6% year-over-year, from $42.86M to $45.69M.
What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s total costs & expenses?
Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s total costs & expenses has grown at a -11.8% compound annual growth rate (CAGR), from $223.57M to $153.29M.
What does total costs & expenses mean?
This metric aggregates all operating and non-operating costs incurred by the company to support its business activities during a specific period. It includes research and development, selling, general, and administrative expenses, as well as any other operational outflows. Analyzing this figure provides a comprehensive view of the company's total burn rate and operational scale.

Ask your AI about Amylyx Pharmaceuticals, Inc.'s total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude